# Aveanna Healthcare Holdings, Inc.: filings

AVAH · Nasdaq · CIK 1832332 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jan 1

Pages: [Overview](/companies/avah.md) · [Financials](/companies/avah/financials.md) · [Filings](/companies/avah/filings.md) · [Insiders](/companies/avah/insiders.md)

## Reports and events: 111 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 178, 8-K 76, 144 39, 3 24, 10-Q 17, S-8 10, CORRESP 8, UPLOAD 7, 10-K 5, 424B4 5, DEF 14A 5, DEFA14A 5, SCHEDULE 13G/A 5, ARS 4, 8-K/A 3, S-1/A 3, SC 13G 3, EFFECT 2, 10-Q/A 1, 424B7 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, PRE 14A 1, S-1 1, S-3 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 20:55 ET | [8-K](/filings/0001193125-26-412540.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-412540 |
| 2026-08-24 | 20:29 ET | [8-K](/filings/0001193125-26-363654.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-363654 |
| 2026-08-13 | 11:00 ET | [10-Q](/filings/0001193125-26-347842.md) | Quarterly report, period 2026-07-04 | 0001193125-26-347842 |
| 2026-08-13 | 11:00 ET | [8-K](/filings/0001193125-26-347840.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-347840 |
| 2026-08-13 | 11:00 ET | [8-K](/filings/0001193125-26-347839.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-347839 |
| 2026-08-07 | 20:43 ET | [8-K](/filings/0001193125-26-340409.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-340409 |
| 2026-06-02 | 11:30 ET | [8-K](/filings/0001193125-26-252511.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-252511 |
| 2026-05-29 | 20:15 ET | [8-K](/filings/0001193125-26-248323.md) | 5.07 Shareholder vote results | 0001193125-26-248323 |
| 2026-05-28 | 12:00 ET | [8-K](/filings/0001193125-26-243028.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-243028 |
| 2026-05-15 | 12:30 ET | [8-K](/filings/0001193125-26-225430.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-225430 |
| 2026-05-14 | 11:00 ET | [10-Q](/filings/0001193125-26-222736.md) | Quarterly report, period 2026-04-04 | 0001193125-26-222736 |
| 2026-05-14 | 11:00 ET | [8-K](/filings/0001193125-26-222735.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-222735 |
| 2026-04-17 | 20:30 ET | [DEF 14A](/filings/0001193125-26-161632.md) | Proxy statement, period 2026-05-29 | 0001193125-26-161632 |
| 2026-03-20 | 11:30 ET | [8-K](/filings/0001832332-26-000002.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001832332-26-000002 |
| 2026-03-19 | 19:33 ET | [10-K](/filings/0001193125-26-115851.md) | Annual report, period 2026-01-03 | 0001193125-26-115851 |
| 2026-03-19 | 11:00 ET | [8-K](/filings/0001193125-26-115114.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-115114 |
| 2026-03-12 | 11:30 ET | [8-K](/filings/0001193125-26-103067.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-103067 |
| 2026-02-27 | 21:30 ET | [8-K](/filings/0001193125-26-082823.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-082823 |
| 2026-02-20 | 21:45 ET | [8-K](/filings/0001193125-26-061523.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-061523 |
| 2026-01-14 | 13:30 ET | [8-K](/filings/0001193125-26-012301.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-012301 |
| 2025-11-14 | 21:15 ET | [8-K](/filings/0001193125-25-282983.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-282983 |
| 2025-11-07 | 12:15 ET | [8-K](/filings/0001193125-25-271016.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-271016 |
| 2025-11-06 | 11:30 ET | [10-Q](/filings/0001193125-25-267978.md) | Quarterly report, period 2025-09-27 | 0001193125-25-267978 |
| 2025-11-06 | 11:30 ET | [8-K](/filings/0001193125-25-267977.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-267977 |
| 2025-10-23 | 20:15 ET | [8-K](/filings/0001193125-25-248773.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-248773 |
| 2025-10-21 | 20:14 ET | [8-K](/filings/0001193125-25-245131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-245131 |
| 2025-09-29 | 21:15 ET | [8-K](/filings/0001193125-25-223435.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-223435 |
| 2025-09-18 | 11:30 ET | [8-K](/filings/0001193125-25-206824.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-206824 |
| 2025-08-11 | 00:00 ET | [10-Q/A](/filings/0000950170-25-106110.md) | Quarterly report, amended, period 2025-06-28 | 0000950170-25-106110 |
| 2025-08-08 | 13:00 ET | [8-K](/filings/0000950170-25-105493.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-105493 |
| 2025-08-07 | 10:30 ET | [8-K](/filings/0000950170-25-104525.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-104525 |
| 2025-08-07 | 10:30 ET | [10-Q](/filings/0000950170-25-104528.md) | Quarterly report, period 2025-06-28 | 0000950170-25-104528 |
| 2025-06-27 | 11:30 ET | [8-K](/filings/0000950170-25-090612.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-090612 |
| 2025-06-04 | 11:30 ET | [8-K/A](/filings/0000950170-25-081394.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-081394 |
| 2025-05-09 | 19:30 ET | [8-K](/filings/0000950170-25-067908.md) | 5.07 Shareholder vote results | 0000950170-25-067908 |
| 2025-05-09 | 11:30 ET | [8-K](/filings/0000950170-25-067501.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-067501 |
| 2025-05-08 | 10:30 ET | [10-Q](/filings/0000950170-25-066342.md) | Quarterly report, period 2025-03-29 | 0000950170-25-066342 |
| 2025-05-08 | 10:30 ET | [8-K](/filings/0000950170-25-066341.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-066341 |
| 2025-04-03 | 11:11 ET | [8-K](/filings/0000950170-25-049951.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-049951 |
| 2025-03-28 | 21:23 ET | [8-K](/filings/0000950170-25-046956.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-046956 |
| 2025-03-25 | 20:06 ET | [DEF 14A](/filings/0001193125-25-062528.md) | Proxy statement, period 2025-05-09 | 0001193125-25-062528 |
| 2025-03-14 | 11:30 ET | [8-K](/filings/0000950170-25-039119.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-039119 |
| 2025-03-13 | 17:13 ET | [10-K](/filings/0000950170-25-038504.md) | Annual report, period 2024-12-28 | 0000950170-25-038504 |
| 2025-03-13 | 10:30 ET | [8-K](/filings/0000950170-25-038316.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-038316 |
| 2024-11-08 | 12:35 ET | [8-K](/filings/0000950170-24-123696.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-123696 |
| 2024-11-07 | 11:33 ET | [10-Q](/filings/0000950170-24-122748.md) | Quarterly report, period 2024-09-28 | 0000950170-24-122748 |
| 2024-11-07 | 11:30 ET | [8-K](/filings/0000950170-24-122743.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122743 |
| 2024-11-04 | 12:31 ET | [8-K](/filings/0000950170-24-120285.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-120285 |
| 2024-10-04 | 20:31 ET | [8-K](/filings/0000950170-24-112939.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-112939 |
| 2024-08-09 | 10:57 ET | [8-K](/filings/0000950170-24-094335.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-094335 |

Page 1 of 3. [Older](/companies/avah/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.